Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18911565 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPK1MAOAMAOBFFAR1 | |
| SCHEMBL23618758 | 0.85 | ALDH1A1 (0.48) | ALDH1A1MAPK1MAOAMAOBFFAR1 | |
| SCHEMBL16893596 | 0.85 | ALDH1A1 (0.48) | ALDH1A1MAPK1MAOAMAOBFFAR1 | |
| SCHEMBL29185026 | 0.80 | FFAR1 (0.55) | ALDH1A1MAPK1FFAR1SMN1; SMN2MAPT | |
| SCHEMBL8873004 | 0.79 | ALDH1A1 (0.52) | ALDH1A1MAPK1MAOAMAOBFFAR1 | |
| SCHEMBL942119 | 0.79 | ALDH1A1 (0.52) | ALDH1A1MAPK1MAOAMAOBFFAR1 | |
| SCHEMBL6536310 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPK1MAOAMAOBFFAR1 | |
| SCHEMBL10911324 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPK1FFAR1NPC1DRD2 | |
| SCHEMBL12110732 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPK1MAOAMAOBFFAR1 | |
| Fluoride SCHEMBL1336321 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPK1MAOAMAOBFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2758414-B1 | RUTHENIUM CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS | DOW SILICONES CORP (US) | 2018-11-21 | — | — | EP | claimed |
| US-9480977-B2 | Ruthenium containing hydrosilylation catalysts and compositions containing the catalysts | DOW CORNING CORPORATION (US) | 2016-11-01 | — | — | US | claimed |
| US-20140275329-A1 | Ruthenium Containing Hydrosilylation Catalysts And Compositions Containing The Catalysts | DOW SILICONES CORPORATION | 2014-09-18 | — | — | US | claimed |
| EP-2758414-A2 | RUTHENIUM CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS | Dow Corning Corporation (US) | 2014-07-30 | — | — | EP | claimed |
| WO-2013043787-A2 | RUTHENIUM CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS | DOW CORNING CORPORATION (US) | 2013-03-28 | — | — | WO | claimed |
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2026-02-17 | — | — | US | disclosed |
| EP-4049996-B1 | GLYCOSIDE COMPOUND, AMIDITE COMPOUND, AND PRODUCTION METHOD FOR POLYNUCLEOTIDE USING SAID COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-12509481-B2 | Glycoside compound, amidite compound, and production method for polynucleotide using said compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12509483-B2 | Method for producing nucleic acid oligomers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | INTOCELL, INC. (KR) | 2025-11-25 | — | — | US | disclosed |
| US-20250213712-A1 | ANTIBODY DRUG CONJUGATES COMPRISING CAMPTOTHECIN DERIVATIVES AND USES THEREOF | INTOCELL, INC. (KR) | 2025-07-03 | — | — | US | disclosed |
| US-12274898-B2 | Substituted benzodiazepines as antibody-drug conjugates | INTOCELL, INC. (KR) | 2025-04-15 | — | — | US | disclosed |
| EP-0194554-B1 | PROCESS FOR PRODUCTION OF OXIME DERIVATIVES | NIPPON ZEON CO., LTD. (JP) | 1993-09-01 | — | — | EP | disclosed |
| US-4906768-A | Process for production of oxime derivatives | NIPPON ZEON CO., LTD. (JP) | 1990-03-06 | — | — | US | disclosed |
| WO-1988001619-A1 | 1'-METHYL-BETA-LACTAM COMPOUNDS AND THEIR PRODUCTION | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1988-03-10 | — | — | WO | disclosed |
| EP-0119457-B1 | AGENT FOR REGULATING THE GROWTH OF PLANTS | BAYER AG (DE) | 1986-12-30 | — | — | EP | disclosed |
| EP-0194554-A2 | Process for production of oxime derivatives | NIPPON ZEON CO., LTD. (JP) | 1986-09-17 | — | — | EP | disclosed |
| EP-0052799-B1 | D-HOMO STEROIDS, THEIR UTILIZATION AND PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1985-01-30 | — | — | EP | disclosed |
| US-4361578-A | ANTIANDROGENS | ALIG L | 1982-11-30 | — | — | US | disclosed |
| EP-0052799-A1 | D-homo steroids, their utilization and preparation and pharmaceutical compositions containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509483-B2 | Method for producing nucleic acid oligomers | POLM, RNGTT, POLRMT | ALDH1A1 4313/4885MAPK1 4470/4885MAOA 3925/4885 |
| US-20250213712-A1 | ANTIBODY DRUG CONJUGATES COMPRISING CAMPTOTHECIN DERIVATIVES AND USES THEREOF | CD47, TOP2A, SSB | ALDH1A1 2732/4885MAPK1 3141/4885MAOA 3461/4885 |
| US-12551570-B2 | Compounds comprising cleavable linker and uses thereof | FCGR2A, FCGR3B, FCGR1A | ALDH1A1 4586/4885MAPK1 3340/4885MAOA 2177/4885 |
| US-12479927-B2 | Compounds comprising cleavable linker and uses thereof | VIP, ANTXR2, TNFRSF9 | ALDH1A1 4822/4885MAPK1 2334/4885MAOA 1804/4885 |
| US-12509481-B2 | Glycoside compound, amidite compound, and production method for polynucleotide using said compounds | RNMT, NOP10, PNP | ALDH1A1 4503/4885MAPK1 1125/4885MAOA 2062/4885 |
| US-12274898-B2 | Substituted benzodiazepines as antibody-drug conjugates | GABRA3, GABRA6, GABRA4 | ALDH1A1 207/4885MAPK1 4089/4885MAOA 405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.